Minghua Li - SHANDONG LUOXIN CEO

CEO

Ms. Li Minghua is Executive Director, General Manager, Chief Executive Officer and Head Research and Development at Shandong Luoxin Pharmacy Stock Co Ltd. She is responsible for assisting the Chairman of the Company in the Companys overall business development and operation. She graduated from Shenyang Pharmacy University with a bachelors degree in Pharmacy. Ms. Li is a senior professional engineer in medicine in the PRC certified by Hei Long Jiang Human Resource Department and a registered practising pharmacist. Before joining the Company in 2001, Ms. Li had over 15 years experience working in several pharmaceutical enterprises in the PRC. Ms. Li was granted the Qi Lu Female Inventor award in 2010. She is a delegate of the Fei County Peoples Congress. Ms. Li is currently a director of Shandong Yuxin Pharmacy Company Limited. since 2013.
Age 48
Tenure 11 years
Phone86 53 9824 1226
Webhttp://www.luoxin.cn

SHANDONG LUOXIN Management Efficiency

The company has return on total asset (ROA) of 8.17 % which means that it generated a profit of $8.17 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on equity (ROE) of 12.54 %, meaning that it generated $12.54 on every $100 dollars invested by stockholders. SHANDONG LUOXIN's management efficiency ratios could be used to measure how well SHANDONG LUOXIN manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Found 7 records

CEO Age

Eric MettemeyerEastern Co
N/A
David ShewmakerEastern Co
N/A
Tom CreganEastern Co
N/A
Thomas CreganEastern Co
N/A
Steven AbramsonUniversal Display
72
August VlakEastern Co
57
Mark HernandezEastern Co
56
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. SHANDONG LUOXIN PHRM [SLUXF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

SHANDONG LUOXIN PHRM Leadership Team

Elected by the shareholders, the SHANDONG LUOXIN's board of directors comprises two types of representatives: SHANDONG LUOXIN inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SHANDONG. The board's role is to monitor SHANDONG LUOXIN's management team and ensure that shareholders' interests are well served. SHANDONG LUOXIN's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SHANDONG LUOXIN's outside directors are responsible for providing unbiased perspectives on the board's policies.
Guanhua Du, Independent Non-Executive Director
Zhenhai Liu, Non-Executive Director
Yun Chen, Independent Non-Executive Director
Zhenteng Liu, Executive Director
Baoqi Liu, Chairman and Compliance Officer
Yu Chen, Vice General Manager of Production Department and Executive Director
Tin Foo, Independent Non-Executive Director
Hongzheng Fu, Independent Non-Executive Director
Chuangui Yin, Non-Executive Director
Fengsheng Han, Secretary of the Board and Executive Director
Minghua Li, CEO, Head of RandD Department, General Manager and Executive Director
Hon Lau, Financial Controller, Company Secretary

SHANDONG Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is SHANDONG LUOXIN a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Consideration for investing in SHANDONG Pink Sheet

If you are still planning to invest in SHANDONG LUOXIN PHRM check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SHANDONG LUOXIN's history and understand the potential risks before investing.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Transaction History
View history of all your transactions and understand their impact on performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities